June 28, 2018 (Noon - 1:30 p.m. ET)
Sponsor/Co-Sponsor(s)
Obstetric and Pediatric Pharmacology and Therapeutics Branch (OPPTB), Best Pharmaceuticals for Children Act (BPCA), NICHD
Purpose
Cardiomyopathy during infancy and childhood can lead to death in infants and children. It also contributes to cardiomyopathies in adults. Cardiomyopathy is the leading cause of heart transplant for children and teenagers and results in considerable health care costs.
Steven E. Lipshultz, M.D., FAAP, FAHA, will discuss causes, risk factors and biomarkers for infants and children with cardiomyopathy and heart failure, as well as preventive strategies that may improve outcomes.
Contact
George Giacoia, OPPTB, NICHD
Phone: (301) 496-5589
E-mail: giacoiag@mail.nih.gov
BACK TO TOP